Join the InvestorsHub Community

I think he meant Jack-axxer - though I tried to find that ID elsewhere on iHub but I couldn't find it either.

Nothing yet. https://www.courtlistener.com/docket/66579590/northwest-biotherapeutics-inc-v-canaccord-genuity-llc/?filed_after=&filed_before=&entry_gte=&entry_lte=&order_by=desc

Is there any update or status on the court's ruling on the Motion to Dismiss? I would look in Pacer, but I don't have the case caption. TIA

DD, if one were a naked short, what would they need right now before NWBO perhaps releases incontrovertible good news with easy to determine PPS increase impact? Answer: Naked shorts would need lots of available shares at low borrowing rates in order to cover (perhaps in dark exchange). And why would brokers, who set those rates, be compelled to make a huge amount of short shares available at low rates so that naked shorts might cover? Perhaps because they would be on the hook if the naked shorts don’t cover.

If true, and if that’s what’s up, it may, as you say, become more clear on Monday.

Well said Doc 💡🏆👍💰

Amen to that

Thank you for responding. I believe that I comprehend your perspective much more accurately now. Happy Holidays.

Shorts both naked and legit have to have collateral and the buy ins will come when the collateral runs out or a margin call would get met with more collateral. Don’t confuse the issue with people selling shares either naked or legit in accounts that don’t have collateral. In order to sell short you need collateral and maintain that position with funds if needed or it gets closed

flipper44,

I don’t see a mea culpa. I see what the company has done with regard to strategic use of safe harbor statements and I have said this off and on for years. When I say the company used longs it’s because they needed long support any way they could get it and they have said they appreciate that support but they most certainly have taken advantage of that relationship with the understanding that they expected those who stuck it out with them would be the ones eventually rewarded. They also understand why there are longs that trade in and out or have traded in and out with some of their shares. Opportunity cost and time is not on every investor’s side. Pretty obvious that thermo has been truthful about this and I shared that I bought extra shares that I later sold back only to build my position up well beyond that point afterwards consistent with my long term goal to accumulate when the market makers and traders work the cycles. I have shared the baseline uptrend from the double bottom in March/April 2020 that all longs could have been using to continue building share count over time if they so chose. Even though I have been off with time line expectations, as most of us hoped for artisan method approval to come sooner, I have always stated I am in to the end. I can point back to earlier posts if anyone would chose to disagree with this.
You wrestled with the need for Edens manufacturing that they did not have vs artisan being able to supply demand and pointed out the potential of side by side BLA preparedness in the last 24 hours. Obviously something else seemed to be required of them than artisan method based on all the delays to submission.
How long have I been focused on manufacturing? The constraints on availability caused by product release restrictions, mentioned specifically by NWBO, were supposed to be able to be overcome on paper with artisan methods but somehow the company couldn’t seem to get an earlier BLA done with that method even after the MIA certification which was likely based on it. NWBO has been buying time in my opinion and investors were just supposed to continue trusting and supporting them in that effort because they could not spell it out without getting hammered by short sellers and longs willing to exit then repurchase later which would have meant even more dilution than has taken place by having everyone expecting everything at any time. The bears have consistently tried to separate loyal longs from management by painting management as adversarial self interested parties. I don’t believe that for one minute but neither will they spell everything out for investors because of how that would be used against them. Hence, the use of safe harbor and longs needing to understand and learn how to deal with it over all these years. We have all been willing participants at this table with the hope and expectation that the basis for our investment is sound and leads to the better day for patients and well deserved reward for those who ground it out with NWBO to the finish. Best wishes.

Your shares are still real and will transfer to another firm for sale, go research amc/ gme and educate yourself

There is no counterfeit shares, when you buy a share it is real and will never be subject to to scrutiny, this is a real desperate attempt to confuse and scare people

the immune response. I was wondering if you as an expert has seen anything like this. Thank you. pic.twitter.com/tJgUC6h30D

— d_stock (@d_stock07734) December 6, 2023

#dcvax #allsolidtumors $nwbo #gbm https://t.co/rr8sWdB8tF

— Peter Davis (@peter_brit) December 7, 2023

T regulatory cell depletion can restore post-vaccination antibody production in rats endogenously expressing the antigen.

To cure #cancer you need to break tolerance...this is what $NWBO is doing with dendritic cells$TSOIhttps://t.co/fKMgLF6C8F

— Dr. Thomas Ichim (@exosome) December 6, 2023

What happens if the firm involved in naked shorting cannot pay the debt and goes bankrupt (without meeting margin call) and the platform fails? Are we insured for what the SP was when they went BK or what we paid to buy the shares?

That’s the issue I see and would like addressed if this naked shorting stuff is real.

$NWBO As an aside I urge all of you to write your US Representatives and Senators regarding @AlMusella ‘s bill “The Promising Pathway Act”. This is important and extremely relevant in today’s regulatory environment that protects Big Pharma over innovative start up biotech. pic.twitter.com/UIIHK7UT9U

— Gregory Zivic, MD (@metacollectiveG) December 6, 2023

Bio99
@BIO99_BIO99

Manufacturing, manufacturing, manufacturing... That's why $NWBO cares so much about it and the details of its submissions... Nothing is being left to chance.

#dcvax #allsolidtumors $nwbo #gbm https://t.co/amRv6UCfGq

— Peter Davis (@peter_brit) December 7, 2023

Yes I believe so and that is the problem shorts, both legit and more so naked, find themselves in and is why the pressure on the stock is so strong

This is all bologna.

Come on man get real.

DCVax-L will be approved by all 4 regulators and the platform will succeed.

The naked shares that are out there when covered will buy on the open market driving the price up but each share that they buy will cancel out 1 naked share. That are not buying specific shares that one would call counterfeit because every long hold a legit share and anyone of those shares will cover the naked share , the problem for the naked share holder is he needs to buy and has to pay up until nwbo share holders sell, that is where the term diamond hands comes from , you never sell and you get the amc/ gme effect

It needs to be the standard response to all of x's posts.

Otherwise it's all for not

Naked shorts are sold creating long positions that people bought, but those shares are no different then any other share. The only thing is there is an account out there that has a negative number of shares in it with a debit balances against the position. That naked position will have to be covered at some time if the company stays in business. If the stock goes up the debit becomes greater and at some point the firm where the naked position will not carry the debt and force a buy in if a margin call isn’t met. This is why the shorts in nwbo are at great risk and the only thing to do is keep naked shorting to keep the price down and now they can only hope the company goes bankrupt and the platform fails.

Take it up with Kusterer since you think he’s a Basher. He raised the scare tactics:

More Nonsense from a BASHER

Wow, McHenry won't run for re-election. As Chair of House Financial Services Cmte he's been one of the staunchest supporters of the status quo in markets and a huge impediment to reform. This is a big deal.https://t.co/rFIEdpD9jt

— Dave Lauer (@dlauer) December 6, 2023

GermanCol,

I assume you are from Germany. I have a question: Was it mandatory before 2023 that clinical trial in EU must be registered on the following website so that the public can have access?

https://www.clinicaltrialsregister.eu/

The reason I am asking is that there is no trace on the collaboration trial between Merck and NWBO.

https://nwbio.com/nw-bio-announces-phase-ii-clinical-trial-program-combining-dcvax-l-and-pembrolizumab-keytruda-for-colorectal-cancer/

I’ve answered this multiple times including a few minutes ago. That’s not what his personal decisions say at all. That is spin. Australia is an entirely different regulatory universe on the other side of the world. Many cancer doctors in the U.S. have not heard of most treatments in trials, if they have not been validated by a regulator. Much misinformation has been spread about this treatment that it is far under the radar. Trying to turn some doctors decision on the opposite end of the world into a moment of non-validation is sheer idiocy.

DD In my neck of the woods that phrase is" YOU ARE PREACHING TO THE CHOIR"

There are many doctors all over the world pursuing all kinds of ideas and theories. Motivation is not the issue. And then further this treatment is not available in Australia and did not run trials there. Given the broad lack of knowledge in the U.S., and assumptions thrown at the trial, until it is validated by regulators, it’s very unlikely that every oncology doctor in Australia is going to know of or focus on this treatment. Seems quite unlikely honestly.

Can’t you put a sell limit order for your shares, at like $25, to keep them from loaning them out? That’s what I did but who knows if it works.

Yes. It’s important to take time in these different wild claims to really investigate those behind them and what their motivations are, as well as the basic details of the claims made. And this stuff can become a huge time wasting distraction that absorbs the energy of otherwise good people, directing them, as you say, down rabbit holes.

First, it’s the folks promoting naked shorting and the idea of counterfeit shares as a thing doing that includes the person I responded to.

I don’t buy the naked shorting any more than the spoofing that replaced it as the excuse du jour.

But since Kusterer opened the discussion I’m reminding everyone of what accepting this logic could mean (only a lawyer would know for sure):

If a bunch of us bought counterfeit shares, unwittingly, aren’t we on the same footing as Madoff investors who thought they had real equity?

Now we should be insured for the principal we put in if it turns out some or all of our shares are counterfeit.

But I don’t think the broker is necessarily on the hook for more than our principal and if we sell counterfeit shares that go to the moon whereas other shareholders who hold lose everything when the counterfeit is discovered, why do we get to keep our winnings when they get nothing?

In both cases our shares were fake. I could see clawback applying but maybe it doesn’t. If you can show me how our situation would be fundamentally different under the law then please let me know.

I guess we could try to get more than just compensatory damages out of brokers for selling us shares without knowing they came from naked shorting and were likely to be counterfeit. Again that’s a lawyer’s place to understand. I’m not sure that would stop clawback.

Another interesting thing is what about folks who bought what later turn out to be counterfeit shares at a higher price and sold at a lower one? Do they get the difference made up?

Absolutely right GermanCol but let's look carefully at lessons to be learned
from No. 2.

Incredibly stated… but I don’t think he’ll understand (on purpose)!

Thx for great summary!